Prostate cancer (PC) is the prevalent malignancy widespread among men in the Western
World. Prostate specific membrane antigen (PSMA) is an established PC marker and has …

Due to its selective overexpression in prostate cancer (PCa), the prostate-specific
membrane antigen (PSMA) has been recognized as a highly promising target for diagnostic …

Cancer is one of the leading social problems of the modern world. Today prostate cancer is
the second leading cause of cancer deaths among men. Targeted drug delivery is widely …

In the past two decades, extensive efforts have been made to develop agents targeting
prostate-specific membrane antigen (PSMA) for prostate cancer imaging and therapy. To …

In recent years, a number of drugs targeting the prostate-specific membrane antigen (PSMA)
have become important tools in the diagnosis and treatment of prostate cancer. In the …

Prostate-specific membrane antigen (PSMA) targeting radiopharmaceuticals have been
successfully used for diagnosis and therapy of prostate cancer. Optimization of the available …

Prostate cancer (PCa) is the most common malignancy in men worldwide, leading to
substantial morbidity and mortality. At present, imaging of PCa has become increasingly …

Prostate cancer (PCa) is a major cause of mortality and morbidity in Western society today.
Current methods for detecting PCa are limited, leaving most early malignancies …

The validation of prostate specific membrane antigen (PSMA) as a molecular target in
metastatic castration-resistant prostate cancer has stimulated the development of multiple …

Background: Prostate cancer (PCa) is the most common sex-related malignancy with high
mortality in men worldwide. Prostate-specific membrane antigen (PSMA) is overexpressed …